"POWER2DM Evaluation Campaign"
Launched by LEIDEN UNIVERSITY MEDICAL CENTER · Jul 3, 2018
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed T2DM or T1DM
- • Able to self-monitor and work with computer and smart phone with internet connections (as assessed by researcher)
- Exclusion Criteria:
- • Severe renal insufficiency (eGFR\<30ml/min)
- • Serious/severe comorbidity that interferes with diabetes outcomes or diabetes self-management including but not limited to: psychiatric diseases, chronic hepatopathy, active malignancy, chronic obstructive pulmonary disease (COPD), disease of the digestive tract, endocrine disorders, cerebrovascular disease with disability
- • For female participants: pregnancy or wanting to become pregnant in the coming 9 months
- • Concurrent participation in other clinical trials
- • Any other situation in which the investigator identifies a potential risk of not being able to perform the study.
About Leiden University Medical Center
Leiden University Medical Center (LUMC) is a prominent academic medical center located in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and high-quality patient care. As a clinical trial sponsor, LUMC focuses on translating scientific discoveries into effective therapies, fostering collaborations between researchers, clinicians, and industry partners. The center is dedicated to conducting rigorous clinical studies across various medical fields, ensuring adherence to ethical standards and regulatory requirements while prioritizing patient safety and outcomes. Through its multidisciplinary approach, LUMC aims to contribute significantly to the understanding and treatment of complex health conditions, driving progress in personalized medicine and improving global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leiden, Zuid Holland, Netherlands
Córdoba, , Spain
Patients applied
Trial Officials
Jacob Sont, Ph.D.
Principal Investigator
Leiden University Medical Center
Javier Delgado Lista, MD Ph.D.
Principal Investigator
Andaluz Health Service
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials